Antibiotics, peptidoglycan synthesis and genomics: the chlamydial anomaly revisited.
Chopra
Ian
I
Department of Microbiology and Antimicrobial Research Centre, University of LeedsLeeds LS2 9JTlUK.
Storey
Christopher
C
Department of Microbiology and Antimicrobial Research Centre, University of LeedsLeeds LS2 9JTlUK.
Falla
Timothy J
TJ
Department of Microbiology and Antimicrobial Research Centre, University of LeedsLeeds LS2 9JTlUK.
Pearce
John H
JH
Microbial Molecular Genetics and Cell Biology Group, School of Biological Sciences, University of BirminghamBirmingham 815 21Tl UK.
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001426:Bacterial Proteins / Q000378:metabolism; D002689:Chlamydia / Q000187:drug effects* / Q000235:genetics* / Q000378:metabolism; D002690:Chlamydia Infections / Q000188:drug therapy / Q000382:microbiology; D016680:Genome, Bacterial; D006801:Humans; D010457:Peptidoglycan / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D010457:Peptidoglycan